INVA250516P22500
- 0.00
- 0.000.00%
Innoviva Newsroom
Rep. George Whitesides Has Sold Up to $5.18M Worth Of Innoviva Stock: Here's What You Should Know
Congress Trade: Representative George Whitesides Just Disclosed New Stock Trades
Innoviva on Pace for Largest Percent Increase Since May 2024 -- Data Talk
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Innoviva, Inc. (NASDAQ:INVA) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Innoviva | 10-K/A: Annual report (Amendment)
13D Filings -- Barron's
WEX, Lamb Weston, and More Stocks See Action From Activist Investors -- Barrons.com
Express News | Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement With Innoviva
Press Release: Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement With Innoviva
Scotiabank Initiates Coverage On Innoviva With Sector Outperform Rating, Announces Price Target of $55
Innoviva Analyst Ratings
Innoviva Insider Sold Shares Worth $28,395,442, According to a Recent SEC Filing
Innoviva(INVA.US) 10% Shareholder Sells US$28.4 Million in Common Stock
Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference
Innoviva Full Year 2024 Earnings: EPS: US$0.37 (Vs US$2.75 in FY 2023)
Innoviva | 10-K: FY2024 Annual Report
Innoviva | 8-K: Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress